Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
Canadian company Valeant was previously in talks to buy Salix for $158 and have been outbid.
"Endo is offering to pay from $170 to $175 a share in cash and stock for Salix, topping Valeant’s agreement to pay $158 a share, the person said, asking not to be identified discussing private information. Endo’s proposal may be announced as soon as Wednesday, the person said."
